Procedures for which BCBS Michigan is clarifying guidelines will appear under Policy Clarifications.
|81228, 81229, S3870||Basic Benefit Policy Clarification|
Genetic testing-array comparative genomic hybridization (ACGH) for the genetic evaluation of patients with developmental delay, mental retardation or autism spectrum disorder remains established. The policy was renamed to "Genetic Testing-Chromosomal Microarry (CMA) Analysis for the Genetic Evaluation of Patients with Developmental Delay/Intellectual Disability or Autism Spectrum Disorder." Additionally, procedure codes *81228 and *81229 were added to the policy as not payable, effective March 1, 2012.